Each 5 mL syrup contains: Ambroxol Hydrochloride 15 mg.
Each mL oral drops contains: Ambroxol Hydrochloride 6 mg.
Ambroxol Hydrochloride is a derivative of the mucolytic, Bromhexine, which has been found to posses secretolytic and mucokinetic properties. It acts by increasing the production of serum concentrations of the bronchial mucus-secreting glands in the respiratory tract. Through its pulmonary surfactant stimulating activity, Ambroxol Hydrochloride accelerates mucus transport, promoting expulsion of thick, tenacious secretions from the respiratory tract.
During treatment with Ambroxol Hydrochloride, chronically inflamed bronchial mucosa tend to return to normal. The patients cough and sputum volumes is reduced; expectoration is facilitated; and breathing is eased considerably.
The good tolerability of Ambroxol Hydrochloride permits its long-term use.
Other Services
Country
Account